Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Audin
- Development stage
- Unknown
- Lead developer
- Laboratoires Holistica
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Audin (also marketed as Avodin or Avoudin) is a natural dietary supplement developed by Arian Salamat Sina under license from Holistica. It is formulated as an oral capsule containing a combination of avocado-soybean unsaponifiables (ASU), ginger extract, and natural vitamin D3. Audin is primarily indicated for the management of osteoarthritis, joint pain, and muscle aches. The avocado-soybean unsaponifiables in Audin stimulate collagen and proteoglycan synthesis to promote cartilage repair and slow the progression of osteoarthritis. The ginger extract acts as a natural anti-inflammatory agent by inhibiting cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, thereby reducing the production of inflammatory prostaglandins and leukotrienes. Vitamin D3 is included to support bone health and prevent deficiency, which is a risk factor for joint inflammation and osteoporosis.
- Brand names
- AvodinAvoudin
02
Targets
ALOX5 (Arachidonate 5-lipoxygenase)VDR (Vitamin D receptor)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Audin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Audin.